(39) - The Impact of the Heart Allocation Policy Change on Pre-LVAD Temporary Mechanical Circulatory Support Utilization and on Outcomes

Autor: Alexy, T., Mudy, K., Airhart, S., Shaffer, A., Kay, J., Emerson, D., Castleberry, A., Hyden, M., Christophy, A., Sun, B.

Publikováno v: In Journal of Heart and Lung Transplantation April 2024 43(4) Supplement:S28-S28

Challenges and opportunities for modeling aging and cancer.

Autor: Anczuków O; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. Electronic address: olga.anczukow@jax.org., Airhart S; The Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA., Chuang JH; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Coussens LM; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA., Kuchel GA; UConn Center on Aging, University of Connecticut School of Medicine, Farmington, CT, USA., Korstanje R; The Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA., Li S; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Lucido AL; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., McAllister SS; Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard and MIT, Cambridge, MA, USA; Harvard Stem Cell Institute, Cambridge, MA, USA., Politi K; Departments of Pathology, and Medicine (Section of Medical Oncology), Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; The Broad Institute of MIT and Harvard, Cambridge, MA, USA; The Ludwig Center at Harvard, Boston, MA, USA; Harvard Stem Cell Institute, Cambridge, MA, USA., Ratliff T; Department of Comparative Pathobiology, Purdue University, West Lafayette, IN, USA., Ren G; The Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA., Trowbridge JJ; The Jackson Laboratory for Mammalian Genetics, Bar Harbor, ME, USA., Ucar D; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Palucka K; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. Electronic address: karolina.palucka@jax.org.

Publikováno v: Cancer cell [Cancer Cell] 2023 Apr 10; Vol. 41 (4), pp. 641-645. Date of Electronic Publication: 2023 Mar 30.

Grace Under Pressure.

Autor: Sweitzer NK; Cardiovascular Medicine, Sarver Heart Center, University of Arizona, Tucson (N.K.S.)., Burkhoff D; Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY (D.B.)., Airhart S; Providence Heart and Vascular Institute, Portland, OR (S.A.)., Fang JC; Division of Cardiovascular Medicine, University of Utah, Salt Lake City (J.C.F.).

Publikováno v: Circulation. Heart failure [Circ Heart Fail] 2022 Feb; Vol. 15 (2), pp. e009513. Date of Electronic Publication: 2022 Feb 09.

Hippo Signaling Pathway in Colorectal Cancer: Modulation by Various Signals and Therapeutic Potential.

Autor: Mohammadpour, Somayeh¹ (AUTHOR), Torshizi Esfahani, Amir¹ (AUTHOR), Sarpash, SeyedKasra² (AUTHOR), Vakili, Fatemeh² (AUTHOR), Zafarjafarzadeh, Nikta² (AUTHOR), Mashaollahi, Amirhesam² (AUTHOR), Pardakhtchi, Ali² (AUTHOR), Nazemalhosseini-Mojarad, Ehsan³ (AUTHOR) ehsanmojarad@gmail.com, Lim, Yun Ping (AUTHOR) limyp@mail2000.com.tw

Publikováno v: Analytical Cellular Pathology: Cellular Oncology. 10/11/2024, Vol. 2024, p1-17. 17p.

Development and characterization of bladder cancer patient- derived xenografts for molecularly guided targeted therapy

Autor: Pan, CX, Zhang, H, Tepper, CG, Lin, TY, Davis, RR, Keck, J, Ghosh, PM, Gill, P, Airhart, S, Bult, C, Gandara, DR, Liu, E, De Vere White, RW

Publikováno v: Pan, CX; Zhang, H; Tepper, CG; Lin, TY; Davis, RR; Keck, J; et al.(2015). Development and characterization of bladder cancer patient-derived xenografts for molecularly guided targeted therapy. PLoS ONE, 10(8). doi: 10.1371/journal.pone.0134346. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/9z84n9wf

Background The overarching goal of this project is to establish a patientderived bladder cancer xenograft (PDX) platform, annotated with deep sequencing and patient clinical information, to accelerate the development of new treatment options for blad

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::f7f6569a1ba67d64ddc867e8349d9855
http://www.escholarship.org/uc/item/9z84n9wf